CERo Therapeutics Holdings, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $1.7M | $3.3M | $96.9K | $475.9K | $1.1M |
| Accounts Receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Total Current Assets | $2.7M | $3.7M | $2.0M | $42.4M | $1.4M |
| Property, Plant & Equipment | $246.1K | $528.5K | $966.7K | — | — |
| Goodwill | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — |
| Total Assets | $3.6M | $6.2M | $5.1M | $42.4M | $180.1M |
| Liabilities | |||||
| Accounts Payable | $7.6M | $4.5M | $1.7M | $1.7M | $14.4K |
| Total Current Liabilities | $9.1M | $7.4M | $3.5M | $30.7M | $98.1K |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $9.1M | $8.1M | $5.1M | $39.9M | $9.2M |
| Stockholders' Equity | |||||
| Retained Earnings | $-90.8M | $-70.9M | $-43.1M | $-11.0M | — |
| Total Stockholders' Equity | $-5.4M | $-1.9M | $-42.1M | $-11.0M | $-7.7M |